Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

Listed in the December 27, 2023 extract; not in the current extract (Aug 26, 2026): Apo-Doxy (00740713), Novo-Doxylin (00725250). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-08-26.xml.

DOXYCYCLINE

All strengths: Off-Formulary Interchangeable, not an ODB benefit; same patient cost rules

Shared coverage and patient cost rules
StatusOff-Formulary Interchangeable, not an ODB benefit
Patient paysPatient pays: program not supplied; amount cannot be determined.

Other products in the same Health Canada class (J01AA) — coverage varies; not interchangeable

  • Minocycline (Minocycline): general benefit, Not a benefit
  • Tetracycline (Tetracyn): general benefit, Not a benefit
  • Tigecycline (Tygacil): general benefit

Apo-Doxycycline MR · DIN 02512645 · 40mg · MR capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Doxycycline MR · DIN 02512645 Manufacturer: Apotex Inc.; listing date 2021-07-30 Health Canada: Marketed since 2021-09-01 · brand APO-DOXYCYCLINE MR · ATC J01AA02 DOXYCYCLINE · form Capsule (immediate- and delayed-release) · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100192 · Verify on the e-Formulary ↗ (DIN 02512645)

Source record
DIN 02512645: Apo-Doxycycline MR Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 081224027; group id 31; item number 0065; lccId None; manufacturer id APX Source form: MR Cap; strength: 40mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $3.1871; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02512645 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=100192
Interchangeable products
Apprilon · DIN 02375885 · not recorded
Shortage status: shortage reported ended 2026-07-03 (report last updated 2026-07-03); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02512645
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apprilon · DIN 02375885 · 40mg · MR capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Savings card: innoviCares lists Apprilon (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
1 brand, same coverage
Apprilon · DIN 02375885 Manufacturer: Galderma Canada Inc; listing date 2021-07-30 Health Canada: Marketed since 2012-11-29 · brand APPRILON · ATC J01AA02 DOXYCYCLINE · form Capsule (immediate- and delayed-release) · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) 40 MG · company Galderma canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Apprilon: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86128 · Verify on the e-Formulary ↗ (DIN 02375885)

Source record
DIN 02375885: Apprilon Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 081224027; group id 31; item number 0065; lccId None; manufacturer id GAC Source form: MR Cap; strength: 40mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02375885 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86128
Interchangeable products
Apo-Doxycycline MR · DIN 02512645 · not recorded
Shortage status: resolved shortage (ended 2024-03-19); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02375885
Shortage record checked 2026-09-13T08:10:21.292534+00:00

DOXYCYCLINE HYCLATE

Form:

10 of 10 products shown

7 general benefit · 3 not a benefit

Other products in the same Health Canada class (J01AA) — coverage varies; not interchangeable

  • Minocycline (Minocycline): general benefit, Not a benefit
  • Tetracycline (Tetracyn): general benefit, Not a benefit
  • Tigecycline (Tygacil): general benefit

Apo-Doxy-Tabs · DIN 00874256 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Doxy-Tabs · DIN 00874256 Manufacturer: Apotex Inc.; listing date 2009-05-20 Health Canada: Marketed since 1990-12-31 · brand APO-DOXY-TABS · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Doxy-Tabs: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10383 · Verify on the e-Formulary ↗ (DIN 00874256)

Source record
DIN 00874256: Apo-Doxy-Tabs Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id APX Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00874256 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10383
Interchangeable products
Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: resolved shortage (ended 2026-09-03); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00874256
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Doxycycline Tablets · DIN 02554372 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Doxycycline Tablets · DIN 02554372 Manufacturer: Jamp Pharma Corporation; listing date 2026-06-30 Health Canada: Marketed since 2026-03-26 · brand JAMP DOXYCYCLINE TABLETS · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Doxycycline Tablets: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=104323 · Verify on the e-Formulary ↗ (DIN 02554372)

Source record
DIN 02554372: Jamp Doxycycline Tablets Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id JPC Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02554372 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=104323
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02554372
Shortage record checked 2026-09-13T08:10:21.292534+00:00

M-Doxycycline · DIN 02543478 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
M-Doxycycline · DIN 02543478 Manufacturer: Mantra Pharma Inc.; listing date 2024-07-31 Health Canada: Marketed since 2024-06-05 · brand M-DOXYCYCLINE · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Mantra pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

M-Doxycycline: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103193 · Verify on the e-Formulary ↗ (DIN 02543478)

Source record
DIN 02543478: M-Doxycycline Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id MAT Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02543478 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103193
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02543478
Shortage record checked 2026-09-13T08:10:21.292534+00:00

NRA-Doxycycline · DIN 02558505 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Doxycycline · DIN 02558505 Manufacturer: Nora Pharma; listing date 2026-03-31 Health Canada: Marketed since 2025-12-12 · brand NRA-DOXYCYCLINE · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Nora pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

NRA-Doxycycline: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106175 · Verify on the e-Formulary ↗ (DIN 02558505)

Source record
DIN 02558505: NRA-Doxycycline Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id NRA Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02558505 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106175
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02558505
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PRZ-Doxycycline · DIN 02536250 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PRZ-Doxycycline · DIN 02536250 Manufacturer: Pharmaris Canada Inc.; listing date 2023-12-29 Health Canada: Marketed since 2023-09-01 · brand PRZ-DOXYCYCLINE · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Pharmaris canada inc · schedule Prescription
Check this DIN again · Health Canada product record

PRZ-Doxycycline: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102504 · Verify on the e-Formulary ↗ (DIN 02536250)

Source record
DIN 02536250: PRZ-Doxycycline Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id PRZ Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02536250 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102504
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02536250
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Doxycycline · DIN 02158574 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Doxycycline · DIN 02158574 Manufacturer: Teva Canada Limited; listing date 2010-12-14 Health Canada: Marketed since 2014-02-07 · brand TEVA-DOXYCYCLINE · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Doxycycline: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18421 · Verify on the e-Formulary ↗ (DIN 02158574)

Source record
DIN 02158574: Teva-Doxycycline Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id TEV Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02158574 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18421
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: resolved shortage (ended 2026-04-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02158574
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Doxycycline · DIN 02528568 · 20mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Doxycycline · DIN 02528568 Manufacturer: Jamp Pharma Corporation; listing date 2024-06-28 Health Canada: Marketed since 2024-05-03 · brand JAMP DOXYCYCLINE · ATC A01AB22 DOXYCYCLINE · form Capsule · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 20 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101777 · Verify on the e-Formulary ↗ (DIN 02528568)

Source record
DIN 02528568: Jamp Doxycycline Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 081224028; group id 32; item number 0066; lccId None; manufacturer id JPC Source form: Cap; strength: 20mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $1.3538; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02528568 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101777
Interchangeable products
PMS-Doxycycline · DIN 02247104 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02528568
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Doxycycline · DIN 02247104 · 20mg · capsule

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Doxycycline · DIN 02247104 Manufacturer: Pharmascience Inc.; listing date 2024-06-28 Health Canada: Marketed since 2025-12-01 · brand PMS-DOXYCYCLINE · ATC A01AB22 DOXYCYCLINE · form Capsule · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 20 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Doxycycline: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71343 · Verify on the e-Formulary ↗ (DIN 02247104)

Source record
DIN 02247104: PMS-Doxycycline Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 081224028; group id 32; item number 0066; lccId None; manufacturer id PMS Source form: Cap; strength: 20mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247104 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71343
Interchangeable products
Jamp Doxycycline · DIN 02528568 · not recorded
Shortage status: resolved shortage (ended 2022-11-18); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02247104
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Doxycycline Tablets · DIN 02351242 · 100mg · tablet

General benefitDormant since 2026-07-23 · checked 2026-09-02 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Doxycycline Tablets · DIN 02351242 Manufacturer: Sanis Health Inc.; listing date 2011-09-15 Health Canada: Dormant since 2026-07-23 · brand DOXYCYCLINE TABLETS · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Doxycycline Tablets: Formulary list price $0.4560/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.4560 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83643 · Verify on the e-Formulary ↗ (DIN 02351242)

Source record
DIN 02351242: Doxycycline Tablets Raw flags: sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id SAI Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.4560; ministry $0.4560 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02351242 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83643
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560 Vibra-Tabs · DIN 00578452 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02351242
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2026-07-23 — choose a marketed DIN from the same-category list.

Vibra-Tabs · DIN 00578452 · 100mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2014-04-04 — choose a marketed DIN from the same-category list.Discontinued 2014-04-04 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2014-04-04 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2014-04-04 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Vibra-Tabs · DIN 00578452 Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01 Health Canada: Cancelled post market since 2014-04-04 · brand VIBRA-TABS · ATC J01AA02 DOXYCYCLINE · form Tablet · route Oral · ingredients DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100 MG · company Pfizer canada ulc · schedule Prescription
Check this DIN again · Health Canada product record

Vibra-Tabs: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6795 · Verify on the e-Formulary ↗ (DIN 00578452)

Source record
DIN 00578452: Vibra-Tabs Raw flags: notABenefit=Y, sec3=Y Item: 081224015; group id 32; item number 0067; lccId None; manufacturer id PFI Source form: Tab; strength: 100mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00578452 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6795
Interchangeable products
Apo-Doxy-Tabs · DIN 00874256 · $0.4560 Doxycycline Tablets · DIN 02351242 · $0.4560 Jamp Doxycycline Tablets · DIN 02554372 · $0.4560 M-Doxycycline · DIN 02543478 · $0.4560 NRA-Doxycycline · DIN 02558505 · $0.4560 PRZ-Doxycycline · DIN 02536250 · $0.4560 Teva-Doxycycline · DIN 02158574 · $0.4560
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00578452
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2014-04-04 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (08:12:24 Tetracyclines) and how they are covered

Matched class: 08:12:24 Tetracyclines

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: TIGECYCLINE Some products covered without a code (check the product listing): MINOCYCLINE HCL, TETRACYCLINE 08:12:24 Tetracyclines

MINOCYCLINE HCL

· 4 products · General benefit (2), Listed, not a benefit (2) · strengths: 50mg, 100mg · Cap

TETRACYCLINE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 250mg · Cap

TIGECYCLINE

· 1 products · General benefit · strengths: 50mg/Vial · Pd for Inj-5mLVial Pk (Preservative-Free) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:24
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE APPRILON® (doxycycline) modified-release capsule is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. No meaningful effect was demonstrated for generalized erythema (redness) of rosacea. APPRILON® contains an antibacterial ingredient, doxycycline. Misuse or overuse of APPRILON® could lead to the development of drug-resistant bacteria. To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline, APPRILON® should only be used for the authorized indication and clinical use. Pediatrics (<18 years of age): Safety and efficacy in children below the age of 18 years have not been established. Geriatrics (≥ 65 years of age): Clinical studies of APPRILON did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. https://pdf.hres.ca/dpd_pm/00045712.PDF PM date: May 31, 2018 Source product: APPRILON; DIN 02375885; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
What the Health Canada label says it is for
1. Indications APO-DOXY / APO-DOXY-TABS (doxycycline hyclate) may be indicated for the treatment of: • Pneumonia Single and multilobe pneumonia and bronchopneumonia due to susceptible strains of Streptococcus pneunomiae and other Streptococcus spp., Staphylococcus spp., H. influenzae and Klebsiella pneumoniae. • Other Respiratory Tract Infections Pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis caused by susceptible strains of β- hemolytic Streptococcus, Staphylococcus spp., Streptococcus pneunomiae and H. influenzae. • Genitourinary Tract Infections Pyelonephritis, cystitis, urethritis caused by susceptible strains of Klebsiella spp., Enterobacter aerogenes, E. coli, Enterococcus spp., Staphylococcus spp., Streptococcus spp. and gonococcal urethritis caused by Neisseria gonorrhoeae. In adult patients with urethritis, cervicitis and vaginitis with a positive test for Chlamydia trachomatis and/or Ureaplasma urealyticum, clinical resolution and absence of detectable organisms have only been observed at completion of ORAL therapy with doxycycline. Relapses or reinfection can occur. In these cases, limited data suggest … https://pdf.hres.ca/dpd_pm/00084988.PDF PM date: 2026-06-05 Source product: APO-DOXY-TABS; DIN 00874256; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Apo-Doxycycline MR · DIN 02512645 Shortage status: shortage reported ended 2026-07-03 (report last updated 2026-07-03); confirm supply with the pharmacy; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02512645

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Apo-Doxycycline MR, Apprilon, Jamp Doxycycline, PMS-Doxycycline, Vibra-Tabs: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026